300725 PharmaBlock Sciences
- 35.14
- -1.16-3.20%
PharmaBlock Sciences News
Yakushi Technology: Announcement on Remuneration Plans for Members of the 4th Board of Directors and Supervisory Board
Yakushi Technology: Announcement on the election of the Board of Supervisors for a new term
Yakushi Technology: Announcement on the election of the board of directors for a new term
Yakishi Technology: Notice on Convening the Company\'s Second Extraordinary General Meeting of Shareholders in 2024
Yakushi Technology: Announcement on the Election of Staff Representative Supervisors for the 4th Board of Supervisors
Yakushi Technology: Announcement on the absorption and merger of wholly-owned subsidiaries
Yakushi Technology: Announcement on convertible debt-to-equity swaps in the third quarter of 2024
Yakushi Technology: Announcement on not revising the Yakushi debt-for-equity conversion price downward
Yakishi Technology: An indicative announcement that Yakushi\'s debt conversion may trigger a downward revision of the share conversion price conditions
Pharma Block Sciences: Pharma block sciences' summary table of non-operational fund usage and other related fund transactions for the first half of 2024.
Pharma Block Sciences: Announcement on the provision for asset impairment in the first half of 2024.
Pharma Block Sciences: Announcement on Increasing the Implementation Sites and Extension of Certain Investment Projects using Raised Funds_clean
Pharma Block Sciences: Announcement regarding the debt-for-equity swaps in the second quarter of 2024 for convertible bonds.
Pharma Block Sciences: Announcement on the Appointment of Executive Vice President of the Company.
Pharma Block Sciences: In 2022, Pharma Block Sciences Co., Ltd. in Nanjing issued convertible corporate bonds to unspecified parties on the Growth board. Follow-up rating report for 2024.
Pharma Block Sciences: Announcement on the Progress of Providing Guarantees to Wholly-owned Subsidiaries.
Pharma Block Sciences: Announcement Regarding the Resumption of Stock Conversion for Yaoshi Convertible Bonds.
Pharma Block Sciences: Pharma Block Sciences issued a report on entrusted management of convertible corporate bonds to unspecified parties (2023).
Pharma Block Sciences: Announcement regarding the debt-for-equity swaps conversion price adjustment for the 2023 annual equity distribution of convertible bonds.
Pharma Block Sciences: Notice on the Suspension of Convertible Bonds Conversion into Stocks During the Equity Distribution Period of Yao Shi.
Analysis
Price Target
No Data
No Data